Dyne Therapeutics

Forecast & Rating17 analysts currently cover Dyne Therapeutics, with about 94.1% giving a positive rating — meaning they expect the stock to rise. The average price target is $39.33, about 56.7% upside from the current price of $25.10. Price targets range from $17.00 to $50.00 — a wide spread, showing clear disagreement over just how much Dyne Therapeutics can rise. Historically, about 52.8% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Dyne Therapeutics closely still see room for the stock to rise. Data as of Jul 29, 2026; for reference only and not investment advice.